Study of BEBT-908 in the Relapsed or Refractory Diffuse Large B-cell Lymphoma Subjects
Clinical trial NCT06074107 · COMPLETED
Trial details
- NCT number
- NCT06074107
- Sponsor
- BeBetter Med Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-12
- Primary completion
- 2023-07-17
- Enrollment
- 128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.